TABLE 3

Recommended Transition Schedule From PCV7 to PCV13 Vaccination Among Infants and Children, According to Number of Previous PCV7 Doses Received: Advisory Committee on Immunization Practices, United States, 2010

Infant SeriesBooster Dose, ≥12 moaSupplemental PCV13 Dose, 14–59 mob
2 mo4 mo6 mo
PCV7PCV13PCV13PCV13
PCV7PCV7PCV13PCV13
PCV7PCV7PCV7PCV13
PCV7PCV7PCV7PCV7PCV13
  • a No additional PCV13 doses are indicated for children 12 through 23 months of age who have received 2 or 3 doses of PCV before 12 months of age and at least 1 dose of PCV13 at 12 months of age or older.

  • b For children with underlying medical conditions (see Table 1), a single supplemental PCV13 dose is recommended through the age of 71 months.